Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (81-90 of 459) with videos related to

Pageof 46
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trialsFrancesco Massari, Alessandro Rizzo, Veronica Mollica, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2019
The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signatureGiorgio Santoni, Consuelo Amantini, Federica Maggi, et al.
Frontiers in Immunology|February 20, 2013
The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responsesGiorgio Santoni, Valerio Farfariello, Sonia Liberati, et al.
Current Molecular Pharmacology|July 19, 2013
Expression and function of the transient receptor potential ion channel family in the hematologic malignanciesMaria B Morelli, Sonia Liberati, Consuelo Amantini, et al.
Annals of Translational Medicine|April 30, 2019
Optimizing renal function and outcome of patients with cT2 renal cell carcinomaMatteo Santoni, Giada Maiorani, Luca Faloppi, et al.
Archives of Pathology & Laboratory Medicine|May 28, 2016
Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic SustainabilityRodolfo Montironi, Matteo Santoni, Francesca Tartari, et al.
Current Drug Targets|April 19, 2016
Editorial: Emerging Immunotargets in Genitourinary TumorsRodolfo Montironi, Matteo Santoni, Francesco Massari, et al.
European Urology|November 26, 2018
Re: Friederike Haidl, David Pfister, Axel Heidenreich. Re: Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. Mordasini L, Hechelhammer L, Diener PA, et al. J Vasc Interv Radiol 2018;29:589-97. Eur Urol 2018;74:525-6: Could Morphologic Changes in Periprostatic Arteries Have an Influence on Prostatic Artery Embolization?Alessia Cimadamore, Marina Scarpelli, Matteo Santoni, et al.
Annals of Translational Medicine|April 30, 2019
Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?Vincenzo Di Nunno, Veronica Mollica, Lidia Gatto, et al.
Expert Review of Anticancer Therapy|November 17, 2015
Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinomaFrancesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Pageof 46

Showing results (81-90 of 459) with videos related to

Sort By:
Pageof 46
European Journal of Cancer (Oxford, England : 1990)|July 15, 2021
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trialsFrancesco Massari, Alessandro Rizzo, Veronica Mollica, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 27, 2019
The TRPV2 cation channels: from urothelial cancer invasiveness to glioblastoma multiforme interactome signatureGiorgio Santoni, Consuelo Amantini, Federica Maggi, et al.
Frontiers in Immunology|February 20, 2013
The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responsesGiorgio Santoni, Valerio Farfariello, Sonia Liberati, et al.
Current Molecular Pharmacology|July 19, 2013
Expression and function of the transient receptor potential ion channel family in the hematologic malignanciesMaria B Morelli, Sonia Liberati, Consuelo Amantini, et al.
Annals of Translational Medicine|April 30, 2019
Optimizing renal function and outcome of patients with cT2 renal cell carcinomaMatteo Santoni, Giada Maiorani, Luca Faloppi, et al.
Archives of Pathology & Laboratory Medicine|May 28, 2016
Testing PD-1/PD-L1 Expression in Cancer Therapy: Pathologic Insights and Economic SustainabilityRodolfo Montironi, Matteo Santoni, Francesca Tartari, et al.
Current Drug Targets|April 19, 2016
Editorial: Emerging Immunotargets in Genitourinary TumorsRodolfo Montironi, Matteo Santoni, Francesco Massari, et al.
European Urology|November 26, 2018
Re: Friederike Haidl, David Pfister, Axel Heidenreich. Re: Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. Mordasini L, Hechelhammer L, Diener PA, et al. J Vasc Interv Radiol 2018;29:589-97. Eur Urol 2018;74:525-6: Could Morphologic Changes in Periprostatic Arteries Have an Influence on Prostatic Artery Embolization?Alessia Cimadamore, Marina Scarpelli, Matteo Santoni, et al.
Annals of Translational Medicine|April 30, 2019
Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?Vincenzo Di Nunno, Veronica Mollica, Lidia Gatto, et al.
Expert Review of Anticancer Therapy|November 17, 2015
Targeting fibroblast growth factor receptor (FGFR) pathway in renal cell carcinomaFrancesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Pageof 46